Serodiagnosis of M. pneumoniae infections by enzyme-linked immunosorbent assay (ELISA). by Busolo, F. & Meloni, G. A.
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 56 (1983), 517-521
Serodiagnosis of M. pneumoniae Infections by Enzyme-
Linked Immunosorbent Assay (ELISA)
FRANCO BUSOLO, M.D., AND GIOVANNI ANTONIO MELONI, M.D.
Institute ofMicrobiology, University ofPadua Medical School, Padua, Italy
Received January 4, 1983
The enzyme-linked immunosorbent assay (ELISA) has been used for detection ofantibodies
against Mycoplasma pneumoniae. The results of ELISA and its sensitivity compared with
other serological methods, such as complement fixation (CF), metabolic inhibition (Ml),
mycoplasmacidal test (MC), and radioimmunoprecipitation (RIP) are reported. ELISA and
MC showed greater sensitivity than CF and MI, while RIP showed serum titer two- to 16-fold
higher. ELISA was specific as determined using other human mycoplasma. A simplified
method based on the determination of ELISA antibody end-point titer by a single serum dilu-
tion has been proposed. ELISA presented several advantages: sensitivity, rapidity, and low
cost and, if adequately standardized, could become a reliable method for the serodiagnosis of
M. pneumoniae infection.
The enzyme-linked immunosorbent assay (ELISA), introduced by Engvall and
Perlmann for quantitative determination of antibodies [1], has found wide applica-
tion in the diagnosis of bacterial [2,3], viral [4,5], and parasitic [6] diseases. ELISA
has also been proposed for its simplicity, sensitivity, and specificity for the
serological diagnosis of M. pneumoniae infection [7,8]. The application of ELISA
for detecting anti-M. pneumoniae antibodies, and its sensitivity as compared with
other methods, such as complement fixation (CF), metabolic inhibition (MI),
mycoplasmacidal test (MC), and radioimmunoprecipitation (RIP), are reported
here.
MATERIALS AND METHODS
Mycoplasma
M. pneumoniae (strain 10119) was kindly provided by the National Collection of
Type Culture, Colindale, London, England. The culture conditions have been
previously described [9].
Human Sera
Human sera were obtained from outpatients with suspected primary atypical
pneumonia from the Pediatric Clinic of the University of Padua.
Serological Methods
The sera were examined with complement fixation (CF), metabolic inhibition
(MI), mycoplasmacidal (MC), and radioimmunoprecipitation (RIP) methods as
described in a previous paper [9].
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Preparation ofAntigen-Coated Wellfor ELISA
Linbro-type microtiter plates with flat-bottomed wells (Flow Laboratories) were
used. Preliminary titrations were made to determine the optimal concentrations of
M. pneumoniae. Mycoplasmas were either grown directly in microtiter wells or
alternatively in flasks and after three washings with phosphate buffer solution (pH
7.2) 50 1l of suspension (A660=0.48) containing 25 jg of protein adsorbed onto
microtiter wells and fixed in 10 percent formalin. A more detailed method is
reported elsewhere [8].
Preparation of Conjugated Antibodies
Goat anti-human immunoglobulin G, M, and A combined (IgG-IgM-IgA), IgM
and IgA antisera (Hyland, Costa Mesa, CA) were purified by gel filtration in
Sephacryl S-200 superfine (Pharmacia, Uppsala, Sweden). Fractions were collected
and the antibodies concentrated to 5 mg/ml and then they were coupled with
alkaline phosphatase (Sigma type VII; specific activity: 1,000 U/mg of protein) by
"one-step" procedure as described by Engvall and Perlmann [1]. Conjugated an-
tibodies at 4°C, under sterile conditions, were stored for almost six months without
any appreciable loss in enzymatic orimmunological activity. We have found that for
longer storage they were best preserved in 1 ml aliquots at -80°C. By using a working
solution of 1:200 in PBS-Tween a hundred patients' sera were examined with a
milliliter of concentrated solution.
ELISA
ELISA was performed as previously described [8] with some modifications. The
adsorbed antigen was washed with PBS containing 0.05 percent Tween 20, which
prevented non-specific antibody adsorption to the plastic. Microtiter plates with 50
t1l of different serum dilutions (in PBS-Tween), starting at 1:16, were incubated for
one hour at 37°C. At the end of the incubation period, the plates were washed twice
with PBS-Tween. Fifty Al of conjugated antibody solution, diluted 1:200 in PBS-
Tween, were added to each well and the plates were incubated for one hour at 37°C.
After three washings, 200 itl of p-nitrophenyl phosphate (1 mg/ml) solution in 0.05
M sodium carbonate buffer (pH 9.8) was added, and the plates were maintained for
one hour at 37°C. The reaction was stopped with 50A1 of 3N NaOH. Absorbance at
405 nm was measured by a photometer instrument (Titertek, Multiskan, Flow
Laboratories). Usually, ten patients' sera were tested for each microtiter plate, along
with one negative and one positive reference serum. The serum titer was expressed
by the highest dilution giving absorbance values greater than 0.1.
RESULTS AND DISCUSSION
Figure 1 shows serum titers obtained by ELISA as compared with CF, MI, MC,
and RIP. ELISA titers were in the range 1:16 to 1:2,048 and 43 were higher than
those obtained with MI. Furthermore, 7/80 (8.75 percent) MI-negative sera were
positive when examined by ELISA, indicating a greater sensitivity and giving the
possibility of detecting low antibody levels in the early stages ofM. pneumoniae in-
fection. Statistical analysis showed that the values obtained with ELISA correlated
well with those obtained by the MI method (p < 0.01). The CF method for de-
tecting M. pneumoniae antibodies was of far lower sensitivity. Three of 65 sera
tested which had a CF titer of 1:16 had a markedly higher titer in ELISA. MC and
ELISA had similar sensitivities since most of the values were distributed in the prox-
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FIG. 1. Comparison between the sensitivity of ELISA and other serological methods. These com-
parisons "two by two" were carried out using different sera. In some instances, the same serum was
assayed by more than two methods. Each closed circle represents one patient's serum.
imity of the baseline ofthe scattergram. ELISA did not reach the degree ofsensitivi-
ty of RIP, which showed serum titers two- to 16-fold higher (up to 1:16,000). A
comparative evaluation on the sensitivities of CF, MI, MC, and RIP was also
reported in a previous paper [9].
The specificity of ELISA for serological diagnosis of M. pneumoniae infection
was assessed using eight positive patients' sera and other human mycoplasmas. In
these experiments we used strains from the international collection such as M.
fermentans NCTC 10117, M. hominis PG-21, M. orale I NIH (CH 19299), M. orale
2 NIH (NH 20247), M. salivarium PG-20, and U. urealyticum T-960. Of the eight
sera taken at random from the seroteca, four had low titer (1:64) and four had
higher titers (1:512). Only one out of 1:64 titer serum cross-reacted with M.fermen-
tans. This may be attributed to the fact that the most important antigen of M.
pneumoniae is a glycolipid and the major complement-fixing antigen ofM.fermen-
tans is also found in the lipid fractions and contains glycolipids and phospholipids
[10]. This cross-reactivity did not limit the diagnostic value of the ELISA, since M.
fermentans is not pathogenic for humans, and we have not found asignificant rise in
the antibody titer.
In our study, we have demonstrated that a fourfold rise in titer to M. pneumoniae
occurred in only 50 percent ofpatients. Probably this is due to the insidious develop-BUSOLO AND MELONI
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ment ofthe disease and the acute-phase sera already show high antibody levels when
they are tested with ELISA.
In order to reduce the cost of the assay and to examine more sera in each
microtiter plate, we tried to find a relationship between the absorbance value at the
various sera dilutions and the serum end-point titer. In this way, an absorbance
value determined on a single serum dilution (1:32, in our case) might be interpreted
quantitatively to give the anti-M. pneumoniae end-point titer of that serum. One
hundred and ten ELISA-positive sera were tested, using anti IgG-IgM-IgA con-
jugated antibodies. The regression line with the corresponding standard errors is
shown in Fig. 2. To test the validity of this simplified method, an additional 48
sera were examined in ELISA at a single serum dilution. Only 10 percent of these
sera showed a discrepancy in end-point titer determination. Therefore we suggest
that the simplified method might be the test of choice for epidemiological studies
where a positivity or negativity can be immediately ascertained.
A question arises on the kind of antibodies measured by the different serological
methods. Later serum samples contain a predominance of IgG antibodies which are
more effective in the MI [11], while in CF only IgM and some IgG subclasses are in-
volved. On the other hand, the greater sensitivity of RIP and ELISA might depend
on the ability of these methods to measure antibodies belonging to any molecular
class and reacting not only with glycolipid antigen, but also with other antigens of
the plasma membrane.
In addition, ELISA can be class-specific. Ninety percent of patients with M.
pneumoniae infection had IgM while a lower percentage had IgA. We have found
that IgM antibodies may persist long after one year following the onset of the
disease. This finding was in agreement with the hypothesis that silent infections oc-
cur quite commonly [12] and that M. pneumoniae disease might result from rein-
fection of patients previously sensitized to the organism [13].
In this field, ELISA presents the advantages ofrapidity, low cost, and avoidance
of the problems which might be caused in the MI and MC by the presence of anti-
biotic in the serum. Furthermore, ELISA, if adequately standardized by its adapt-
ability to automation, could become a reliable method for the serodiagnosis of M.
pneumoniae infection.
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